Zhang Rumin, Kavana Michael
Merck Research Laboratories, Department of In Vitro Pharmacology, Kenilworth, New Jersey, USA.
Sci Rep. 2016 Apr 27;6:25158. doi: 10.1038/srep25158.
G protein-coupled receptors (GPCRs) are an important class of drug targets. Quantitative analysis by global curve fitting of properly designed dose-dependent GPCR agonism and allosterism data permits the determination of all affinity and efficacy parameters based on a general operational model. We report here a quantitative and panoramic measure of receptor agonist and modulator equi-response and equi-occupancy selectivity calculated from these parameters. The selectivity values help to differentiate not only one agonist or modulator from another, but on-target from off-target receptor or functional pathway as well. Furthermore, in conjunction with target site free drug concentrations and endogenous agonist tones, the allosterism parameters and selectivity values may be used to predict in vivo efficacy and safety margins.
G蛋白偶联受体(GPCRs)是一类重要的药物靶点。通过对精心设计的剂量依赖性GPCR激动作用和变构作用数据进行全局曲线拟合的定量分析,能够基于通用的操作模型确定所有亲和力和效能参数。我们在此报告一种从这些参数计算得出的受体激动剂和调节剂等反应性及等占据选择性的定量全景测量方法。这些选择性值不仅有助于区分一种激动剂或调节剂与另一种,还能区分靶向受体或功能途径与非靶向受体或功能途径。此外,结合靶点部位的游离药物浓度和内源性激动剂水平,变构参数和选择性值可用于预测体内效能和安全边际。